Recently, Prostate-Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography (PSMA PET/CT) was introduced as a novel imaging technique, improving the prediction of the disease outcome among patients with PCa compared to that of conventional imaging techniques [6]. This evidence concerns the gene FOLH1 and posterior cortical atrophy.